BMS Label Issue Adds To China Drug Shortage Woes

13 Feb 2017

While shortages of some drugs in China are not new, a recent case of a patient scrambling to locate a potentially life-saving chemotherapy to complete their treatment has shone new light on the problem, which the government is taking various steps to combat.

On a quiet afternoon after the Chinese New Year, an emergency request prompted a rush to action as people scrambled to secure supplies of a critical cancer therapy.

The drug in focus was carboplatin, marketed by Bristol-Myers Squibb Co. in China as Paraplatin. As one of several...